• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Huron Consulting Group launches clinical trial data analytics and visualization service

Huron Consulting Group launches clinical trial data analytics and visualization service

August 13, 2014
CenterWatch Staff

Huron Consulting Group, a Chicago, Ill.-based provider of business consulting services, has launched its trialRx service, a Huron Life Sciences clinical trial data monitoring service to help pharma, biotech and device companies understand and mitigate clinical trial disclosure risks.

Huron Life Sciences’ trialRx service is enabled by a unique, proprietary data analytics and visualization tool that leverages a database of the 32 million unique data points available on the NIH’s web site, clinicaltrials.gov. The trialRx service provides an accurate, automated way to monitor clinical trial registration and results reporting compliance, allowing companies to develop focused strategies to mitigate clinical trial disclosure risks efficiently.

“The trialRx service provides life sciences companies with a straightforward, efficient way to monitor all publicly available information posted on clinicaltrials.gov. Based on this information, they can generate insights to inform and support various clinical operations and compliance initiatives,” said Paul J. Silver, managing director and practice leader, Huron Life Sciences. “We developed the trialRx service to further support the strategic, clinical and regulatory compliance needs of our clients in a world where data is everywhere—and where being able to use it is critical.”

The trialRx service equips companies to understand their overall risk exposure on clinicaltrials.gov for each of their clinical trials. Huron’s clients have experienced a reduction in overall noncompliance and realized additional value by using the service to enhance data quality, create business insights and identify operations improvement opportunities. Specifically, clients have used the trialRx service to identify and remediate data quality issues including errant sponsor listings, duplicate secondary IDs, lack of universal trial numbers and identification of non-harmonized study conditions and interventions.

“Our trialRx service fills a distinct need in the marketplace by closing the loop between what is posted by clinical trial sponsors—either manually or using trial data disclosure solutions—and what regulators require,” said BJ D’Avella, director, Huron Life Sciences. “It provides sponsors an efficient, cost-effective way to understand their evolving clinical trial portfolios and can be customized to meet our clients’ unique business and compliance needs.”

Upcoming Events

  • 12Apr

    The Patient Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing